ACC 2025 Insights: Cardiac Function, Clinical Outcomes and Effect of…

ACC 2025 Insights

K. Jering

PET Imagining in Cardiac Amyloidosis

NYU Langone

S. Dorbala

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

How to Make the Diagnosis of ATTR Amyloidosis

Scripps Health

B. Sperry

Integration of CT and MRI Evaluation of Aortic Insufficiency into Ro…

Scripps Health

J. Cavalcante

Transplant in Amyloidosis

Scripps Health

M. Urey

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

Advanced Imaging for the Diagnosis of Cardiomyopathy

Scripps Health

P. Parwani

Cardiomyopathies: 2024 Wrap Up

Cardiology 2024 Year in Review

A. Masri

MRI Imaging in Cardiotoxicity

Scripps Health

P. Parwani

Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

Assessment of Aortic Regurgitation in the Current Era

Houston Methodist DeBakey Heart and Vascular Center

W. Zoghbi

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

Emerging Therapies in Cardiac Amyloidosis

NYU Langone

M. Hanna

Interpreting a PYP Study for TTR Cardiac Amyloid

American Society of Nuclear Cardiology

P. Soman, M. Harinstein, S. Divakaran

Hypertrophic Cardiomyopathy: MRI to Mavacamten

Scripps Health

J. Gonzalez

Amyloidosis Types and Pathophysiology

Houston Methodist

B. Trachtenberg

Cardiac Amyloidosis: Evaluation and New Therapies

Cleveland Clinic Heart, Vascular and Thoracic Institute

M. Hanna

Practical Applications of Cardiac MRI

Collaborative CME and Research Network

K. Hanneman